A study published in Clinical Infectious Diseases examined outcomes for patients with methicillin-susceptible and-resistant Staphylococcus aureus bacteremia, particularly focusing on readmissions.
Researchers conducted a retrospective analysis using the 2014 Nationwide Readmissions Database, which captured 49.3 percent of U.S. hospitalizations. They identified MSSA and MRSA bacteremia among patients older than 18 years and included the results in their analysis.
Of 92,089 patients with S. aureus bacteremia, 48.5 percent had MRSA bacteremia. The 30-day readmission rate was 22 percent overall.
Patients with MRSA bacteremia experienced an increased likelihood of readmission for:
• Bacteremia recurrence
• Higher in-hospital mortality
• Longer hospitalization
The cost of readmission was $12,425 per case overall.